APOE and Alzheimer disease: Our data support these findings by showing significant changes in GSK‐3β phosphorylation levels in ApoE4‐T2DM mice, highlighting the critical role of ApoE4 in mediating AD‐related pathological changes and cognitive impairments via GSK‐3β.